Forziga 10mg (14 Tablet / Pack)
A premium oral SGLT2 inhibitor antidiabetic tablet for blood sugar control and cardiovascular protection.
Forziga 10mg Tablets contain Dapagliflozin, a potent, highly selective sodium-glucose co-transporter 2 (SGLT2) inhibitor engineered for the treatment of Type 2 Diabetes Mellitus and heart failure. Operating independently of insulin, it actively blocks renal glucose reabsorption in the proximal convoluted tubules, promoting the therapeutic excretion of excess glucose directly through the urine.
Purpose
Inhibits renal glucose reabsorption to eliminate excess systemic sugar via the urine, lowering overall HbA1c profiles.
Ingredients
Dapagliflozin 10mg
Warnings
Maintain exceptional personal perineal hygiene to drastically reduce the clinical risk of developing genitourinary infections. Discontinue use immediately and seek urgent emergency care if you experience nausea, vomiting, or deep breathing, which could indicate euglycemic diabetic ketoacidosis (DKA). Monitor volume status and hydration levels closely, particularly in elderly populations or patients taking parallel loop diuretics. Regularly assess baseline and ongoing renal function parameters, as the drug's glycemic efficacy depends on kidney filtration.
Side Effects
Increased frequency of urination and elevated daily urinary volume profiles. Opportunistic genitourinary tract infections, such as vulvovaginal candidiasis or urinary tract infections. Transient mild dizziness, postural hypotension, or dehydration-related thirst. Small, transient shifts in serum creatinine and localized lipid profiles.
Storage Instructions
Store below 30°C in a dry place, keeping the medication safely out of the sight and reach of children.
| Status | Active |